top of page
Tim Worthington photo.jpg

Mr Tim Worthington has been a Consultant Surgeon since 2004, originally working at University College Hospital, London, before being appointed as a Consultant Surgeon at the Royal Surrey County Hospital in 2005.  He has a specialist practice in minimally invasive surgery, complex liver and pancreas surgery and interventional endoscopy.  His appointment coincided with the Royal Surrey being designated as a Specialist Tertiary Referral Centre for complex liver and pancreas disease as part of the ‘Improving Outcome’ guidance by the Department of Health in 2005.  He is a tutor at the Minimal Access Therapy and Training Unit (MATTU) at the University of Surrey and is a course director for postgraduate courses in laparoscopic cholecystectomy and laparoscopic clearance of common bile duct. 


He was a member of the organising committee of the 2015 meeting of the UK and Ireland Pancreatic Society and organised the UK and Ireland endoscopic ultrasound users’ group congress at the same meeting.


Mr Worthington underwent postgraduate training in surgery in London and was awarded a doctorate of medicine from Imperial College London in 2002 for his work on examining the molecular of biology of pancreatic cancer.  He underwent further postgraduate training in Australia, Canada and the United States of America.  In 2014 he was invited to the Mayo Clinic, Minnesota, USA, to work with Professor Michael Kendrick, the acknowledged world expert on minimally-invasive liver and pancreas surgery.  In 2013, 2014 and 2016 Mr Worthington was a member of faculty for the Association of Laparoscopic Surgeons of UK and Ireland meetings and demonstrated minimally-invasive surgical techniques to an audience in the UK and Europe.

Hepatopancreaticobiliary Unit at the Royal Surrey County Hospital
and University of Surrey

The HPB Unit at the Royal Surrey County Hospital consists of a multi-disciplinary team dedicated to the care of patients with complex liver and pancreas pathology.  As part of the ‘Improving Outcomes’ guidance for cancer, the Royal Surrey was designated as a Centre of Excellence in 2005 and it now offers comprehensive treatment for patients with hepatopancreaticobiliary pathology.  The unit performs in excess of one hundred pancreatic and one hundred liver resections each year, with an associated operative mortality in the region of 1%, which is comparable to the best centres in the world.  The Royal Surrey is a leading unit in enhanced recovery following major surgery and as such has excellent results for length of stay and operative morbidity and mortality. 

Mr Worthington leads the unit in the development of minimally-invasive surgery for pancreatic and liver disease and is an acknowledged expert in the field. 

bottom of page